Rankings
▼
Calendar
APLS FY 2015 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
APLS
Apellis Pharmaceuticals, Inc.
$2B
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$47M
Net Income
-$47M
EPS (Diluted)
$-2.57
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$545,701
Balance Sheet
Total Assets
$38M
Total Liabilities
$3M
Stockholders' Equity
$35M
Cash & Equivalents
$36M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$47M
-$11M
-312.4%
Net Income
-$47M
-$11M
-331.2%
← FY 2014
All Quarters
Q1 2016 →